1. How Useful Are Monogenic Rodent Models for the Study of Human Non-Alcoholic Fatty Liver Disease?
   Jake P. Mann et al, 2016, Front. Endocrinol. CrossRef
2. Effect of nuclear factor-κB and angiotensin II receptor type 1 on the pathogenesis of rat non-alcoholic fatty liver disease
   Dao-Yu Tan et al, 2015, WJG CrossRef
3. Chymase Inhibitor as a Novel Therapeutic Agent for Non-alcoholic Steatohepatitis
   Shinji Takai et al, 2018, Front. Pharmacol. CrossRef
4. Irbesartan Ameliorates Lipid Deposition by Enhancing Autophagy via PKC/AMPK/ULK1 Axis in Free Fatty Acid Induced Hepatocytes
   Juan He et al, 2019, Front. Physiol. CrossRef
5. null
   Amira M. Badr et al, 2023 CrossRef
6. Association between Dietary Potassium Intake and Nonalcoholic Fatty Liver Disease and Advanced Hepatic Fibrosis in U.S. Adults
   Hao-Kai Chen et al, 2024, International Journal of Endocrinology CrossRef